[1] Ferrari S, Ronfani L, Calogero S, et al. The mouse gene coding for high mobility group 1 protein (HMG1) [J]. J Biol Chem, 1994, 269(46)∶28803-28808 [2] Taniguchi N, Kawahara K, Yone K, et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine [J]. Arthritis Rheum, 2003, 48(4)∶971-981 [3] Park SY, Lee SW, Kim HY, et al. HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1α activation [J]. European Journal of Immunology, 2015, 45(4)∶1216-1227 [4] Feng Y, Fang W, Li C, et al. The expression of high-mobility group box protein-1 in temporomandibular joint osteoarthritis with disc perforation [J]. J Oral Pathol Med, 2016, 45(2)∶148-152 [5] Li C, Cai H, Meng Q, et al. IL-1beta mediating high mobility group box protein-1 expression in condylar chondrocyte during temporomandibular joint inflammation [J]. J Oral Pathol Med, 2016, 45(7)∶539-545 [6] 袁健,龚忠诚,凌彬,等.透明质酸钠关节下腔注射治疗颞下颌关节盘前移位的疗效分析[J].口腔医学研究,2012,28(11)∶1145-1148 [7] Li C, Long X, Deng M, et al. Osteoarthritic changes after superior and inferior joint space injection of hyaluronic acid for the treatment of temporomandibular joint osteoarthritis with anterior disc displacement without reduction: a cone-beam computed tomographic evaluation [J]. J Oral Maxillofac Surg, 2015, 73(2)∶232-244 [8] Wahamaa H, Schierbeck H, Hreggvidsdottir HS, et al. High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts [J]. Arthritis Res Ther, 2011, 13(4)∶R136 [9] Varoga D, Paulsen F, Mentlein R, et al. TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease [J]. J Pathol, 2006, 210(3)∶315-324 [10] Heinola T, de Grauw JC, Virkki L, et al. Bovine chronic osteoarthritis causes minimal change in synovial fluid [J]. J Comp Pathol, 2013, 148(4)∶335-344 [11] Dicker KT, Gurski LA, Pradhan-Bhatt S, et al. Hyaluronan: A simple polysaccharide with diverse biological functions [J]. Acta Biomaterialia, 2014, 10(4)∶1558-1570 [12] Maharjan AS, Pilling D, and Gomer RH. High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation [J]. PLoS One, 2011, 6(10)∶e26078 [13] Liu-Bryan R. and Terkeltaub R. Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice [J]. Arthritis Rheum, 2010, 62(7)∶2004-2012 [14] Julovi SM, Ito H, Nishitani K, et al. Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38 [J]. J Orthop Res, 2011, 29(2)∶258-264 [15] Mladenovic Z, Saurel AS, Berenbaum F, et al. Potential role of hyaluronic acid on bone in osteoarthritis: matrix metalloproteinases, aggrecanases, and RANKL expression are partially prevented by hyaluronic acid in interleukin 1-stimulated osteoblasts [J]. J Rheumatol, 2014. 41(5)∶945-954 [16] Campo GM, Avenoso A, D'Ascola A, et al. Hyaluronan differently modulates TLR-4 and the inflammatory response in mouse chondrocytes [J]. Biofactors, 2012, 38(1)∶69-76 |